Mental Health Clinician

Skip Nav Destination

Current Issue

Volume 13,

Issue 4

August 2023

View This Issue

Senior Editors

Amy M. VandenBerg, PharmD, BCPP
Erica A. K. Davis, PharmD, BCPS, BCPP

eISSN: 2168-9709

About this Journal

The Mental Health Clinician (MHC) is a peer-reviewed, bimonthly, clinical practice journal indexed in PubMed and PubMed Central (PMC). The MHC delves into new topics with each issue to provide psychiatric and neurologic pharmacists’... Read More

Submit an Article

Latest
Most Read

Increasing access to psychiatric care during the COVID-19 pandemic through mental health clinical pharmacy specialist services

P. Brittany Vickery, PharmD, BCPS, BCPP, CPP, Kacie Godwin, PharmD, J. Kyle Roach, PharmD

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers

Nina Carrillo, PharmD, Maren McGurran, PharmD, BCPS, BCPP, Brittany L. Melton, PharmD, PhD, Karen E. Moeller, PharmD, BCPP

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data

Joshua Caballero, PharmD, BCPP, FCCP, Jianing Xu, MS, Daniel B. Hall, PhD, Xianyan Chen, PhD, Henry N. Young, PhD

A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment

Lauren Denton, PharmD, Amber Kapuganti, PharmD, BCPP, Sarah Kim, MD

Diltiazem for clozapine-induced generalized hyperhidrosis

Emma M. Kenton, PharmD, Samantha M. Zoellner, PharmD Candidate, May 2024, Leigh Anne Nelson, PharmD, BCPP

Features & Information

Psychiatric Pharmacists: Improving Access, Outcomes and Cost

With $238 billion being spent on mental health each year and the growing shortage of psychiatrists, clinical pharmacists will continue to play an essential role on mental health teams. Discover the benefits of having a psychiatric pharmacist as part of the team in collaboration with the health care team, patients and caregivers by downloading these informative resources.

Opioid Use Disorder Education

AAPP’s OUD Education Program is designed to be part of the solution in addressing this public health crisis by educating pharmacists on how to identify patients with OUD, when to refer untreated patients to providers for treatment, how to develop/recommend evidence‐based treatment plans for OUD, and the steps to monitoring prescribed treatments.

A Career in Psychiatric Pharmacy

The demand for psychiatric services to treat psychiatric and neurological disorders has dramatically increased. Psychiatric pharmacists can help meet this demand by working with a physician as part of a collaborative team to improve medication-related outcomes for patients with psychiatric or neurological disorders.